Memantine and blood glucose increased 
Memantine and blood glucose increased Patient Reports February 12, 2012
Memantine Side Effects Report #4627539-8
Memantine side effect was reported by a Physician from on Feb 16, 2005. Male patient, 37 years of age, weighting 208.0 lb, was diagnosed with schizophrenia and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood bilirubin increased, blood glucose increased, blood osmolarity decreased, hypochloraemia, hypokalaemia, inappropriate antidiuretic hormone secretion. Memantine dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, ZYPREXA, VITAMIN B6, CLARITIN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4635920-6
Memantine side effect was reported by a Physician from on Apr 07, 2005. Male patient, 37 years of age, weighting 208.0 lb, was diagnosed with schizophrenia and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, blood glucose increased, blood osmolarity decreased, blood phosphorus decreased, blood thyroid stimulating hormone increased, communication disorder, delirium, depressed level of consciousness. Memantine dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, ZYPREXA, VITAMIN B6, CLARITIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4822902-4
Memantine side effect was reported by a Physician from UNITED STATES on Oct 28, 2005. Male patient, 37 years of age, weighting 208.0 lb, was diagnosed with schizophrenia and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood glucose increased, blood ketone body increased, blood phosphorus decreased, blood thyroid stimulating hormone increased, delusion, dyslipidaemia, feeling abnormal. Memantine dosage: unknown. During the same period patient was treated with LITHIUM, ZYPREXA, VITAMIN B6, CLARITIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4871960-X
Memantine side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anion gap decreased, back pain
, blood albumin decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood pressure diastolic increased, cold sweat, confusional state. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4899938-0
Memantine side effect was reported by a Physician from UNITED STATES on Jan 24, 2006. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anion gap decreased, back pain
, blood albumin decreased, blood chloride increased, blood glucose increased, blood potassium increased, body temperature decreased, cold sweat, confusional state. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4928547-X
Memantine side effect was reported by a Physician from UNITED STATES on Feb 09, 2006. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: back pain
, blood glucose increased, blood pressure diastolic increased, body temperature decreased, cold sweat, confusional state, drooling, haemoglobin decreased, hypotension. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5016920-3
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, weighting 119.4 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal tenderness, arthritis
, asthenia, back pain , blood calcium increased, blood creatinine increased, blood glucose increased, blood magnesium increased, blood urea increased. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM PATCH, ARICEPT. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5016969-0
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, weighting 119.4 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal tenderness, arthritis
, asthenia, blood calcium increased, blood chloride increased, blood creatinine increased, blood glucose increased, blood magnesium increased, blood urea increased. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM PATCH, ARICEPT. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5135621-4
Memantine side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5039830-4
Memantine side effect was reported by a Physician from UNITED STATES on June 13, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, csf white blood cell count increased, diverticulitis intestinal haemorrhagic, leukocytosis. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4602710-X
Memantine side effect was reported by a Physician from on Feb 28, 2005. Male patient, 85 years of age, weighting 153.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood albumin increased, blood chloride increased, blood glucose increased, blood phosphorus decreased, blood potassium increased, bundle branch block left, bundle branch block right, dehydration. Memantine dosage: 20 MG QD PO. During the same period patient was treated with VITAMIN B6, VITAMIN B, VITAMIN C, VITAMIN E, ASPIRIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4622055-1
Memantine side effect was reported by a Physician from on Mar 11, 2005. Male patient, 85 years of age, weighting 153.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatine phosphokinase increased, blood glucose increased, blood phosphorus decreased, blood phosphorus increased, blood urine present, bundle branch block left, bundle branch block right, dehydration. Memantine dosage: 20 MG QD PO. During the same period patient was treated with VITAMIN B6, VITAMIN B, VITAMIN C, VITAMIN E. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5575721-8
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, c-reactive protein increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5692109-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 18, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, cholecystitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.
Memantine Side Effects Report #5832246-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on July 22, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood urea increased, carbohydrate antigen 19-9 increased, cholecystitis, cholelithiasis, enteritis infectious, femoral neck fracture, pneumonia
, pneumonia aspiration. Memantine dosage: 20 MG (20 MG,1 IN 1 D), ORAL. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.Memantine Side Effects Report #5901380-8
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 17, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood potassium decreased, blood triglycerides increased, cholecystitis, cholelithiasis, enteritis infectious, femoral neck fracture, pneumonia
, pneumonia aspiration. Memantine dosage: 20 MG (20 MG, 1 IN 1 D) ,ORAL. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, PROPIVERINE HYDROCHLORIDE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.Memantine Side Effects Report #4587149-8
Memantine side effect was reported by a Health Professional from on Feb 01, 2005. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, atrial fibrillation
, blood chloride increased, blood glucose increased, blood potassium decreased, blood urea increased, bundle branch block left, cardiomegaly, coronary artery atherosclerosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, POTASSIUM CHLORIDE, ZOLPIDEM TARTRATE, ERTHROMYCIN. Patient was hospitalized. Patient died on 11/11/2004.Memantine Side Effects Report #4609121-1
Memantine side effect was reported by a Physician from on Mar 07, 2005. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood chloride increased, blood glucose increased, blood sodium increased, blood urea increased, bundle branch block left, cardiomegaly, coronary artery atherosclerosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, POTASSIUM CHLORIDE, ZOLPIDEM TARTRATE, ERTHROMYCIN. Patient was hospitalized. Patient died on 11/11/2004.
Memantine Side Effects Report #6029407-6
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Dec 25, 2008. Female patient, 83 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bile duct obstruction, blood glucose increased, cholecystitis, hepatic function abnormal, protein total decreased, renal disorder, splenomegaly. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MECOBALAMIN, BETAHISTINE MESILATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #6081481-7
Memantine side effect was reported by a Pharmacist from GERMANY on Feb 02, 2009. Female patient, 83 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: ascites, bile duct obstruction, bile duct stenosis, blood glucose increased, cholangitis, cholecystitis, gallbladder cancer
, metastases to large intestine, metastases to liver. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MECOBALAMIN, BETAHISTINE MESILATE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4662961-5
Memantine side effect was reported by a Health Professional from on May 02, 2005. Male patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood triglycerides increased, blood urea increased, glycosylated haemoglobin increased, renal function test abnormal. Memantine dosage: 15 MG QD PO. During the same period patient was treated with AQUAPHORIL, SERMION, SEROQUEL, AMARYL, XEFO, THROMBO ASS, FAMOTIDIN. Patient recovered.
Memantine Side Effects Report #4673070-3
Memantine side effect was reported by a Health Professional from on May 18, 2005. Male patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood triglycerides increased, blood urea increased, glycosylated haemoglobin increased. Memantine dosage: 15 MG QD PO. During the same period patient was treated with AQUAPHORIL, SERMION, SEROQUEL, AMARYL, XEFO, THROMBO ASS, FAMOTIDIN. Patient recovered.
Memantine Side Effects Report #4988327-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 11, 2006. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, blood chloride increased, blood cholesterol decreased, blood creatinine increased, blood glucose increased, blood pressure increased, blood sodium increased, body temperature decreased. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE. Patient was hospitalized. Patient died on 02/12/2006.
Memantine Side Effects Report #5736300-2
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2008. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type, hypertension, urinary incontinence
and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood urea increased, bradycardia, loss of consciousness, malaise, orthostatic hypotension. Memantine dosage: 10 MG BID PO. During the same period patient was treated with MODUCREN, ARICEPT, TANAKAN, LANSOPRAZOLE, DITROPAN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4947545-3
Memantine side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2006. Female patient, 78 years of age, weighting 125.0 lb, was diagnosed with dementia alzheimer's type, anxiety
and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood bilirubin increased, blood glucose increased, blood pressure systolic increased, chest pain , dizziness , lymphocyte percentage decreased, neutrophil percentage increased. Memantine dosage: 7 MG QD PO. During the same period patient was treated with PAXIL, ISOSORBIDE, ARICEPT, PLAVIX, ASPIRIN, LIPITOR, FOSAMAX, BENICAR. Patient recovered.Memantine Side Effects Report #4956856-7
Memantine side effect was reported by a Physician from UNITED STATES on Mar 15, 2006. Female patient, 78 years of age, weighting 125.0 lb, was diagnosed with dementia alzheimer's type, anxiety
and was treated with Memantine. After drug was administered, patient experienced the following side effects: anxiety , blood bilirubin increased, blood glucose increased, blood pressure systolic increased, chest pain , dizziness , lymphocyte count decreased. Memantine dosage: 7 MG QD PO. During the same period patient was treated with PAXIL, ISOSORBIDE, ARICEPT, PLAVIX, ASPIRIN, LIPITOR, FOSAMAX, BENICAR. Patient recovered.Memantine Side Effects Report #5633808-5
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 30, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, altered state of consciousness, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood magnesium increased, blood sodium decreased, blood urea increased. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.
Memantine Side Effects Report #5121923-4
Memantine side effect was reported by a Health Professional from BELGIUM on Sept 04, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood uric acid decreased, cognitive disorder, depressed level of consciousness, diabetes mellitus inadequate control, disorientation, disturbance in social behaviour, dizziness
, glycosylated haemoglobin increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAN, PANTOPRAZOLE, DIAMICRON. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5173225-8
Memantine side effect was reported by a Health Professional from BELGIUM on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, agitation, blood glucose increased, cholecystitis acute, depressed level of consciousness, gait disturbance, glabellar reflex abnormal, glycosylated haemoglobin increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAM, PANTOZOL, DIAMICRON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5805297-9
Memantine side effect was reported by a Physician from UNITED STATES on June 23, 2008. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute prerenal failure, agitation, aphagia, bacteria urine, blood chloride increased, blood glucose increased, blood ph decreased, body temperature increased, carbon dioxide decreased. Memantine dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #6081483-0
Memantine side effect was reported by a Health Professional from GERMANY on Feb 10, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood glucose increased, blood uric acid increased, deep vein thrombosis
, fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhage, platelet count decreased. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #6122223-6
Memantine side effect was reported by a Health Professional from GERMANY on Mar 04, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood creatine increased, blood glucose increased, blood uric acid increased, deep vein thrombosis
, epilepsy , gamma-glutamyltransferase increased, international normalised ratio decreased. Memantine dosage: 20 MG (20 MG,1 IN 1 D),ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5505165-6
Memantine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, aortic thrombosis, aspiration, blood glucose increased, blood phosphorus increased, bronchopneumonia, cardiac arrest
, cardio-respiratory arrest, cerebellar atrophy. Memantine dosage: 28 MG QD;PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VATAMINS, PLAQUENIL, VITAMIN E. Patient was hospitalized. Patient died on 07/18/2007.Memantine Side Effects Report #5513946-8
Memantine side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, arteriosclerosis, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine increased, blood gases abnormal, blood glucose increased, blood phosphorus increased, blood urine present. Memantine dosage: 28 MG QD PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VITAMIN CAP, PLAQUENIL, VITAMIN E. Patient was hospitalized. Patient died on 07/18/2007.
Memantine Side Effects Report #5533936-9
Memantine side effect was reported by a Physician from UNITED STATES on Nov 26, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood creatinine increased, blood gases abnormal, blood glucose increased, blood phosphorus increased, blood urine present, body temperature increased, brain natriuretic peptide increased, bronchopneumonia. Memantine dosage: 28 MG QD PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VITAMIN CAP, PLAQUENIL, SYNTHROID. Patient was hospitalized. Patient died on 07/18/2007.
Memantine Side Effects Report #5016915-X
Memantine side effect was reported by a Health Professional from UNITED STATES on May 19, 2006. Male patient, 69 years of age, weighting 165.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, agitation, alanine aminotransferase decreased, blood chloride decreased, blood glucose increased, blood thyroid stimulating hormone decreased, blood urea nitrogen/creatinine ratio decreased, hallucination, visual. Memantine dosage: unknown. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5067213-X
Memantine side effect was reported by a Health Professional from JAPAN on July 20, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, albumin globulin ratio abnormal, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.Memantine Side Effects Report #5120003-1
Memantine side effect was reported by a Health Professional from JAPAN on Sept 22, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, cough, depressed level of consciousness, diffuse large b-cell lymphoma stage iv. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #4913543-9
Memantine side effect was reported by a Health Professional from JAPAN on Jan 31, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aspartate aminotransferase increased, band neutrophil percentage increased, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE, HYDROXYZINE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4922747-0
Memantine side effect was reported by a Health Professional from JAPAN on Feb 10, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4937122-2
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4988330-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #4990003-0
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Apr 25, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #6140009-3
Memantine side effect was reported by a Health Professional from GERMANY on Mar 18, 2009. Male patient, weighting 154.3 lb, was diagnosed with dementia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood sodium decreased, febrile infection, inflammation, somnolence, syncope. Memantine dosage: 20 MG (20 MG, 1 IN 1 D),ORAL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5016935-5
Memantine side effect was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 87 years of age, weighting 116.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood glucose increased, blood pressure diastolic decreased, body temperature decreased, confusional state, drooling, haemoglobin decreased, hypotension, lethargy. Memantine dosage: unknown. During the same period patient was treated with NORVASC, OSTEOBIFLEX, PRINIVIL, ASPIRIN, LIDODERM, ARICEPT. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5468661-6
Memantine side effect was reported by a Health Professional from FRANCE on Sept 06, 2007. Male patient, 79 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood sodium increased, dehydration, lung infection, renal failure acute, somnolence. Memantine dosage: 10 MG QD PO. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE, ARICEPT, DEROXAT, RISPERDAL. Patient was hospitalized. Patient recovered.